Correlation Between Minimum Inhibitory Concentration and Clinical Outcome of Invasive Fusariosis
Completed
- Conditions
- Invasive Fusariosis
- Registration Number
- NCT04982159
- Lead Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Brief Summary
Multi-centered, international, observational and retrospective study to analyze the correlation between MIC and clinical outcome in patients with invasive fusariosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
- Invasive fusariosis diagnostic
- Proof of anti-fungic susceptibility according to EUCAST or CLSI, for the medicine used in the treatment of invasive fusariosis.
- Available data about anti-fungic medicines used: name of medicine, start and end date of treatment.
- Available information about clinical outcome of illness after 30 days, 6 weeks and 90 days (dead or alive).
- Only cases of invasive fusariosis proven or possible will be included.
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Evolution 6 weeks after diagnosis Retrospective evaluation of death rate.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital Universitario Reina Sofía
🇪🇸Córdoba, Spain
Hospital Universitario Reina Sofía🇪🇸Córdoba, Spain